ARCHIVES

Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

Scientific Community Rallies To Support DeVita; Immediate Suspension Of Straus’ Grant Considered

June 12, 1981

Blood Cancers Advocacy Groups Seek DOD And NCI Funds, Medicare Coverage.

July 6, 2001

FDA Puts Clinical Hold On Gene Therapy Trials

January 24, 2003

John Durant Names ASCO Executive NP; A New Position, New Voice In Washington

December 2, 1994

Minnesota Study Aimed At Finding Final Answer On Hemoccult Screening

July 24, 1987

In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril

May 30, 1975